Tags : Registration Certificate

Biocad with its Partner ICM Received the Registration Certificate for

The partner received Registration Certificate for its Acellbia (biosimilar, rituximab) and Herticad (biosimilars, trastuzumab) in Bosnia and Herzegovina, countries on the Balkan Peninsula in Southeastern EU. The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina has granted certificate with expected market launch in this year Biocad will be responsible to produce agents […]Read More